Funds back US pharma

Hedge Funds Bet on Rising US Healthcare Stocks Near 5-Year High, Says Goldman Sachs

Goldman Sachs reports hedge funds are increasing exposure to US healthcare stocks near five-year highs, driven by AI-driven drug discovery breakthroughs and favorable financing conditions. The sector